Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom. [PDF]
Lorenzi M +7 more
europepmc +1 more source
Choroidal Neovascularization and Extensive Macular Atrophy With Pseudodrusen: a Retrospective Comparative Case Series. [PDF]
Hilgert CR +5 more
europepmc +1 more source
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy. [PDF]
Fukuda Y +4 more
europepmc +1 more source
Role of Angiogenesis in Retinal Diseases and New Advances in Drug Development. [PDF]
Boey E, Zaidi H, Tang T, Yazdanyar A.
europepmc +1 more source
Cost-effectiveness analysis of Brolucizumab compared to Aflibercept and Ranibizumab in nAMD with persistent retinal fluid. [PDF]
García-Serrano Fuertes R +6 more
europepmc +1 more source
Impact of anti-VEGF therapy on choroidal thickness in patients with retinal vein occlusion: a systematic review and meta-analysis. [PDF]
Cheng X +5 more
europepmc +1 more source
Signals of Drug-Related Retinal Fibrosis: Findings From a 20-Year Disproportionality Analysis of Global Spontaneous Reports. [PDF]
Wei M +7 more
europepmc +1 more source
Myocardial Infarction, Stroke, and Death after Intravitreal Injection of Anti-VEGF in a Nationwide Study. [PDF]
Conese C +8 more
europepmc +1 more source
Computational Fluid Dynamics Modeling of Intravitreal Ranibizumab Bolus Versus Subretinal ABBV-RGX-314 Transgene Product in Human Eyes. [PDF]
Park J, Kazemi M, Tamhane M, Shen J.
europepmc +1 more source

